• Mitochondrial Repair in Diabetic Periodontitis

  2026-09-08

  The reference study introduces a hierarchically targeted, ROS-responsive hydrogel that delivers MitoQ to mitochondria within M1 macrophages in diabetic periodontitis. Its results support a treatment strategy that combines local retention, inflammation-triggered release, mitochondrial repair, and restoration of the periodontal bone-forming environment.

• Drug Repurposing for CRISPR DNA Repair Control

  2026-09-07

  This study screened 7,240 drug conditions in human induced pluripotent stem cells to identify compounds that shift CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. The work also implicates ESR2 and AOX1 in repair regulation and provides a framework for combining pharmacological perturbation with genome editing and synthetic-lethality studies.

• Homoharringtonine N1504: Reliable Cell Assays

  2026-09-07

  This scenario-based guide explains how Homoharringtonine (SKU N1504) can support reproducible viability, proliferation, leukemia research, and SARS-CoV-2 antiviral research workflows. It covers mechanism, solvent compatibility, assay optimization, interpretation, and practical product-selection criteria grounded in product specifications and peer-reviewed evidence.

• EZ Cap EGFP mRNA 5-moUTP: Assay Design

  2026-09-05

  EZ Cap EGFP mRNA 5-moUTP is more than a fluorescent reporter: its cap, modified uridine, and poly(A) architecture make it a practical probe for separating delivery from translation. This guide shows how to use enhanced green fluorescent protein mRNA to design more interpretable cellular and in vivo assays.

• Oleic Acid C18:1(9Z) Assay Workflows

  2026-09-04

  Build reproducible hepatocyte lipid-loading, signaling, inflammation, and cancer assays with Oleic Acid C18:1(9Z). This workflow emphasizes controlled fatty-acid delivery, mechanistic readouts, matched controls, and troubleshooting for translating liver-injury findings into practical bench experiments.

• CGP 55845 Hydrochloride in GABAB Translation

  2026-09-04

  A translational framework for using CGP 55845 hydrochloride to separate GABAB receptor signaling from astrocytic GAT-3 mechanisms in synaptic transmission research, neurotransmitter release modulation, and hypoglycemia mechanism study workflows.

• Cycloastragenol in Glucocorticoid-Induced Osteonecrosis

  2026-09-03

  The 2024 Journal of Orthopaedic Translation study shows that cycloastragenol protects against methylprednisolone-associated femoral-head damage in rats by restraining osteoclast activity, preserving trabecular structure, and improving local blood supply. Its value is mechanistic as well as therapeutic: the work links glucocorticoid-induced osteonecrosis to altered RANKL–OPG signaling and provides a framework for evaluating bone-preserving interventions.

• Cefiderocol Against Resistant European Nonfermenters

  2026-09-03

  This European surveillance study directly compared cefiderocol with established and emerging β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Its combination of broad isolate sampling, resistance stratification, PCR, and whole-genome sequencing shows why cefiderocol susceptibility testing may retain value when conventional options are compromised.

• Ambroxol Targets Nav1.8, TRPV1, and TRPA1

  2026-09-02

  This 2025 Journal of Pain study defines a multi-target electrophysiological profile for ambroxol, showing species-dependent Nav1.8 inhibition alongside weaker modulation of human TRPV1 and TRPA1. Its findings provide a mechanistic rationale for topical analgesia while highlighting why rodent Nav1.8 data should not be transferred directly to human pain biology.

• Bestatin as a Chemical Genetics Tool for Jasmonate Signaling

  2026-09-02

  The reference study established Bestatin as a chemical probe for jasmonate signaling in Arabidopsis and tomato, rather than merely as an aminopeptidase inhibitor. By combining gene-expression analysis, pharmacological comparisons, developmental phenotyping, and screening for bestatin-resistant mutants, the authors identified regulators and response classes that help dissect COI1-dependent jasmonate biology.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-01

  Xiao et al. identify CH25H and lysosomal 25-hydroxycholesterol as an immunometabolic checkpoint that connects sterol handling to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows that targeting this axis can improve T-cell surveillance and enhance anti-PD-1 efficacy, providing a mechanistic framework for studying macrophage-mediated tumor immune suppression.

• CGP 55845 hydrochloride in Synaptic Assays

  2026-09-01

  CGP 55845 hydrochloride gives researchers a selective way to separate GABAB receptor signaling from astrocytic GAT-3 mechanisms in dentate gyrus experiments. This practical guide combines concentration planning, electrophysiology workflows, neurotransmitter release modulation, and troubleshooting for reproducible in vitro studies.

• Early Life Adversity, Oxytocin, and Innate Fear

  2026-08-31

  Tan and colleagues show that social deprivation during a defined early-life window weakens looming-evoked innate defensive behavior in mice through reduced oxytocin signaling in the intermediate and deep superior colliculus. By combining behavioral testing, receptor knockdown, circuit analysis, and intranasal oxytocin rescue, the study connects early adversity with a specific threat-processing pathway while highlighting important limits for clinical translation.

• Ertapenem and the Mobility of Carbapenem Resistance

  2026-08-31

  Ertapenem is more than a broad-spectrum susceptibility reagent: it can help translational researchers connect PBP inhibition, carbapenemase activity, plasmid mobility, and strain relatedness. This thought-leadership guide uses recent CREC surveillance findings from Guangdong to outline a mobility-aware framework for antibiotic resistance research.

• Protease Inhibitor Cocktail for NPC Workflows

  2026-08-30

  Protect protein endpoints in DHODH and TP53 experiments with a broad-spectrum lysis strategy that covers multiple protease classes. The separate EDTA component enables metalloprotease control when compatible, while selective omission or removal supports IMAC, kinase, and other metal-sensitive workflows.

8179 records 5/546 page Previous Next 12345 下5页 Last page